US FDA approves higher dose of Regeneron’s eye disease drug Eylea By Reuters
[ad_1] © Reuters. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020....
US FDA approves Biogen-Sage Therapeutics pill for postpartum depression By Reuters
[ad_1] © Reuters (Reuters) -The U.S. Food and Drug Administration (FDA) on Friday approved Biogen (NASDAQ:) and Sage Therapeutics’ oral pill to treat postpartum depression...
Mesoblast shares tank after US FDA rejects cell therapy for children By Reuters
[ad_1] © Reuters. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020....
US FDA grants standard approval of Eisai/Biogen Alzheimer’s drug By Reuters
[ad_1] © Reuters. FILE PHOTO: The Alzheimer’s drug LEQEMBI is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai/Handout via...
US FDA declines to approve Regeneron’s higher-dose Eylea, shares tumble By Reuters
[ad_1] © Reuters. FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company’s Westchester campus in Tarrytown, New York, U.S....
Neuralink gets FDA approval for ‘in-human’ trials of its brain-computer interface By Cointelegraph
[ad_1] Elon Musk’s brain-computer interface (BCI) startup, Neuralink, reportedly received approval from the United States Food and Drug Administration (FDA) to conduct some form of...
Neuralink gets FDA approval for ‘in-human’ trials of its brain-computer interface By Cointelegraph
[ad_1] Elon Musk’s brain-computer interface (BCI) startup, Neuralink, reportedly received approval from the United States Food and Drug Administration (FDA) to conduct some form of...
Neuralink gets FDA approval for ‘in-human’ trials of its brain-computer interface By Cointelegraph
[ad_1] Elon Musk’s brain-computer interface (BCI) startup, Neuralink, reportedly received approval from the United States Food and Drug Administration (FDA) to conduct some form of...
US FDA approves Pharming’s immune disorder drug By Reuters
[ad_1] © Reuters. FILE PHOTO: FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August...
U.S. FDA approves bluebird bio’s gene therapy for a rare neurological disorder By Reuters
[ad_1] © Reuters. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020....